Hamilton Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Hamilton Capital's BMY Position: Q1 2023 in Review
Hamilton Capital sold out of Bristol-Myers Squibb (BMY) in Q1 2023, closing a stake of 7,342 shares — an estimated $528K sold.
Hamilton Capital first reported a position in BMY in Q1 2022 and held it in 3 quarters. The position peaked at $528K in Q4 2022. 2,540 funds tracked by Wall St. Rank hold BMY as of Q1 2023.
- Hamilton Capital reported no remaining Bristol-Myers Squibb position as of Q1 2023 after selling out during the quarter.
- Hamilton Capital sold 7,342 Bristol-Myers Squibb shares in Q1 2023, an estimated $528K.
- Hamilton Capital first reported a position in Bristol-Myers Squibb in Q1 2022 and held it in 3 quarters.
- Hamilton Capital's Bristol-Myers Squibb position peaked at $528K in Q4 2022.
- 2,540 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2023.
Based on Hamilton Capital's 13F filing for Q1 2023, filed 3 May 2023.